MYGN:NASDAQ
Myriad Genetics Inc
$4.21
arrow_downward
-1.64%(-0.070) 1D
Oct 7, 12:27:36 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MYGN...
Open
$4.25
High
$4.32
Low
$4.12
Mkt. cap
402.68M
Avg. vol.
2.01M
Volume
357.78K
52-wk high
$8.59
52-wk low
$2.74
EPS
-$1.20
Beta
1.64
Shares outstanding
95.65M
No. of employees
3K
Open
$4.25
High
$4.32
Low
$4.12
Mkt. cap
402.68M
Avg. vol.
2.01M
Volume
357.78K
52-wk high
$8.59
52-wk low
$2.74
EPS
-$1.20
Beta
1.64
Shares outstanding
95.65M
No. of employees
3K
News stories
From web sources and news partners
AD HOC NEWS
·
1 day ago
Craig-Hallum raises target for Myriad Genetics stock from USD 4.00 to USD 8.00
Profile
Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a patient's likelihood of responding to a particular drug therapy, assess a patient's risk of disease progression and disease recurrence, and measure disease activity. Wikipedia
About Myriad Genetics Inc
CEOPaul J. Diaz | Paul J. Diaz
Employees2.7K
Founded1991
HeadquartersSalt Lake City, Utah, United States
SectorBiotechnology
Websitemyriad.com